313
Participants
Start Date
January 31, 2012
Primary Completion Date
February 28, 2013
Study Completion Date
February 28, 2013
GW685698/GW642444
ICS/LABA
CCI18781
ICS
GSK Investigational Site, Quezon City
GSK Investigational Site, Lipa City
GSK Investigational Site, Beijing
GSK Investigational Site, Beijing
GSK Investigational Site, Beijing
GSK Investigational Site, Shenyang
GSK Investigational Site, Shenyang
GSK Investigational Site, Shanghai
GSK Investigational Site, Shanghai
GSK Investigational Site, Shanghai
GSK Investigational Site, Chongqing
GSK Investigational Site, Chongqing
GSK Investigational Site, Changsha
GSK Investigational Site, Ilsanseo-gu, Goyang-si, Gyeonggi-do
GSK Investigational Site, Guangzhou
GSK Investigational Site, Bucheon-si, Gyeonggi-Do
GSK Investigational Site, Cheongju, Chungcheongbuk-do
GSK Investigational Site, Pusan
GSK Investigational Site, Seongnam-si, Gyeonggi-do
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
Lead Sponsor
GlaxoSmithKline
INDUSTRY